tiprankstipranks
Insperity (NSP)
NYSE:NSP
Want to see NSP full AI Analyst Report?

Insperity (NSP) AI Stock Analysis

392 Followers

Top Page

NSP

Insperity

(NYSE:NSP)

Select Model
Select Model
Select Model
Neutral 51 (OpenAI - 5.2)
Rating:51Neutral
Price Target:
$32.00
â–²(10.73% Upside)
Action:Reiterated
Date:05/21/26
The score is held back primarily by weak financial performance—losses, compressed margins, and high leverage on a thin equity base—despite a rebound to positive cash flow. Support comes from attractive valuation (low P/E and high dividend yield) and a somewhat improving operating narrative from the earnings call (margin recovery and reiterated EBITDA guidance), while technicals suggest only a moderate recovery within a longer-term downtrend.
Positive Factors
Recurring PEO revenue model
Insperity’s core PEO model generates recurring, payroll-linked service fees and pass-through administration at scale. That fee-per-employee structure creates predictable, contractually recurring revenue and client stickiness from bundled payroll, benefits and compliance services, supporting mid-term revenue resilience and predictable cash flows.
Negative Factors
Elevated leverage and thin equity
Very high leverage relative to a small equity base constrains financial flexibility and raises solvency risk if earnings or cash flow weaken. Interest and covenant exposure limit strategic optionality, amplify volatility from losses, and reduce the company’s ability to pursue growth investments or absorb adverse benefit-claim cycles.
Read all positive and negative factors
Positive Factors
Negative Factors
Recurring PEO revenue model
Insperity’s core PEO model generates recurring, payroll-linked service fees and pass-through administration at scale. That fee-per-employee structure creates predictable, contractually recurring revenue and client stickiness from bundled payroll, benefits and compliance services, supporting mid-term revenue resilience and predictable cash flows.
Read all positive factors

Insperity Key Performance Indicators (KPIs)

Any
Any
Revenue by Geography
Revenue by Geography
Breaks down where Insperity earns sales across regions, highlighting geographic strengths and concentration risk. Regional trends reveal growth opportunities, exposure to local economic cycles or regulatory changes, and where the company’s sales and marketing efforts are most effective.
Chart InsightsInsperity’s revenue recovery is concentrated in the Northeast, but 2025 features a pronounced Q1 spike across regions followed by sequential softening — consistent with a seasonal or one‑time payroll/booking surge rather than durable demand acceleration. Management’s call flags a tepid hiring backdrop and only modest workforce growth, while pricing actions and a UnitedHealthcare agreement should stabilize revenue and blunt benefit-cost pressure; however, margin recovery and sustainable organic expansion remain uncertain given elevated health costs and hiring challenges.
Data provided by:The Fly

Insperity (NSP) vs. SPDR S&P 500 ETF (SPY)

Insperity Business Overview & Revenue Model

Company Description
Insperity, Inc. provides human resources (HR) and business solutions to improve business performance for small and medium-sized businesses. The company offers its HR services through its Workforce Optimization and Workforce Synchronization solutio...
How the Company Makes Money
Insperity generates most of its revenue through its PEO services, where client companies enter a co-employment arrangement and Insperity provides an integrated package of HR-related services. Under this model, Insperity bills clients based largely...

Insperity Earnings Call Summary

Earnings Call Date:Apr 30, 2026
(Q1-2026)
|
% Change Since: |
Next Earnings Date:Aug 03, 2026
Earnings Call Sentiment Neutral
The call portrayed a company in recovery: solid early progress on margin restoration (improved gross profit trends, controlled operating expenses, improved benefit-cost dynamics) and a promising HRScale rollout and AI strategy that can drive medium-term growth. Offsetting these positives are near-term headwinds—declining worksite employee counts, lower new-sales activity, elevated attrition tied to margin actions, a significant Q1 tax-related EPS hit and seasonal cash pressure. Management maintained full-year adjusted EBITDA guidance but lowered unit guidance, signaling confidence in profitability recovery while acknowledging slower top-line momentum.
Positive Updates
Adjusted EBITDA and EPS Beat Midpoint
Adjusted EPS of $1.31 and adjusted EBITDA of $103 million in Q1 2026 both exceeded the midpoint of guidance; adjusted EBITDA was up 1% versus $102M in Q1 2025.
Negative Updates
Worksite Employee Base Contraction
Average paid worksite employees were 303,049 in Q1 2026, a 1.0% decrease versus Q1 2025; full-year WSE guidance downgraded to 303,000–307,000 (a decline of 1.0%–2.3% vs 2025) and Q2 WSE expected down 1.5%–2.1% YoY.
Read all updates
Q1-2026 Updates
Negative
Adjusted EBITDA and EPS Beat Midpoint
Adjusted EPS of $1.31 and adjusted EBITDA of $103 million in Q1 2026 both exceeded the midpoint of guidance; adjusted EBITDA was up 1% versus $102M in Q1 2025.
Read all positive updates
Company Guidance
Insperity reiterated full‑year adjusted EBITDA guidance of $170M–$230M while trimming unit guidance to 303,000–307,000 average paid worksite employees for 2026 (a 1.0%–2.3% decline vs. 2025) and guiding Q2 WSEs to 302,500–304,500 (down 1.5%–2.1% yoy); full‑year adjusted EPS is $1.60–$2.60 (Q2 $0.02–$0.50) with a FY adjusted tax rate of ~36% and ~38.5M weighted average shares outstanding. In Q1 the company reported adjusted EPS of $1.31 and adjusted EBITDA of $103M, average paid WSEs of 303,049 (‑1.0% vs. Q1 2025), total gross profit of $302M (‑3%), gross profit per WSE of $332/month, benefit cost per covered employee +5% yr/yr (improved from ~9% last year), operating expenses $240M (‑1%; ‑5% ex $9M restructuring), $13M invested in HRScale in Q1 ($8M opex, $5M capex), $36M adjusted cash, $23M dividends paid, 171k shares repurchased for $4M, and ~$380M unused credit capacity (~$330M available); management expects a flatter quarterly earnings pattern due to UnitedHealthcare pooling change ($1M→$500k).

Insperity Financial Statement Overview

Summary
Despite sharp TTM revenue growth (+47%), profitability has deteriorated into losses (negative EBIT and net income TTM) with meaningful margin compression (gross margin down to ~12.9% from ~16–17%). Balance sheet risk is elevated due to very high debt-to-equity (~6.4x TTM) and thin equity, limiting flexibility. Cash flow has rebounded to positive (TTM FCF $67M), but multi-year volatility keeps quality mixed.
Income Statement
38
Negative
Balance Sheet
27
Negative
Cash Flow
44
Neutral
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.84B6.81B6.58B6.49B5.94B4.97B
Gross Profit881.00M900.00M1.05B1.04B1.01B820.10M
EBITDA36.00M35.00M198.00M295.00M300.29M214.32M
Net Income-25.00M-7.00M91.00M171.00M179.35M124.08M
Balance Sheet
Total Assets2.20B2.20B2.60B2.12B2.04B1.75B
Cash, Cash Equivalents and Short-Term Investments555.00M660.00M1.05B709.00M765.90M607.60M
Total Debt430.00M435.00M435.00M427.00M424.99M433.59M
Total Liabilities2.13B2.16B2.50B2.03B1.96B1.75B
Stockholders Equity67.00M46.00M97.00M94.00M81.28M-1.77M
Cash Flow
Free Cash Flow67.00M-309.00M482.00M158.37M317.36M227.25M
Operating Cash Flow98.00M-278.00M520.00M198.49M347.69M260.15M
Investing Cash Flow-31.00M-31.00M-38.00M-21.73M-32.12M-31.01M
Financing Cash Flow-87.00M-90.00M-173.00M-155.01M-141.15M-208.07M

Insperity Technical Analysis

Technical Analysis Sentiment
Positive
Last Price28.90
Price Trends
50DMA
28.90
Positive
100DMA
31.18
Positive
200DMA
36.98
Negative
Market Momentum
MACD
0.48
Positive
RSI
55.03
Neutral
STOCH
64.33
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For NSP, the sentiment is Positive. The current price of 28.9 is below the 20-day moving average (MA) of 31.61, below the 50-day MA of 28.90, and below the 200-day MA of 36.98, indicating a neutral trend. The MACD of 0.48 indicates Positive momentum. The RSI at 55.03 is Neutral, neither overbought nor oversold. The STOCH value of 64.33 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for NSP.

Insperity Risk Analysis

Insperity disclosed 1 risk factors in its most recent earnings report. Insperity reported the most risks in the "Legal & Regulatory" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Insperity Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$3.53B13.7313.94%2.89%5.44%8.92%
65
Neutral
$774.12M-12.3417.82%0.88%7.12%-21.18%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
57
Neutral
$1.97B4.81179.66%1.81%-1.40%-0.67%
53
Neutral
$2.79B45.8710.14%8.65%-6.08%-35.51%
51
Neutral
$1.22B7.72-32.05%6.37%3.04%-140.22%
49
Neutral
$1.37B137.58-0.81%4.96%4.77%-115.03%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
NSP
Insperity
32.09
-28.87
-47.36%
BBSI
Barrett Business Services
31.52
-9.18
-22.55%
KFY
Korn Ferry
68.03
2.47
3.77%
MAN
ManpowerGroup
29.37
-10.94
-27.14%
RHI
Robert Half
27.31
-14.32
-34.39%
TNET
TriNet Group
42.78
-36.75
-46.21%

Insperity Corporate Events

Executive/Board ChangesShareholder Meetings
Insperity Shareholders Approve Directors, Pay and Incentive Plan
Positive
May 20, 2026
On May 18, 2026, Insperity held its 2026 annual stockholders meeting at its headquarters in Kingwood, Texas, where shareholders re-elected four Class I directors—Timothy T. Clifford, Ellen H. Masterson, Latha Ramchand and W. Philip Wilmingto...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: May 21, 2026